News & Media
Latest from Syntropic.
Press releases, clinical milestones, publications, and awards from our expanding research programme.
15 April 2026
Reopening the Brain’s Window of Plasticity
How flickering light triggers the brain’s own immune cells to dismantle the molecular brakes on learning and recovery. Based on: Venturino et al., Cell Reports,…
Read more →19 March 2026
Syntropic Honored at the U.S. Embassy Vienna
Syntropic Honored at the U.S. Embassy in Vienna Credits: Vitor Goncalves. Syntropic wins 1st prize at the national preliminary round for the SelectUSA Investment Summit,…
Read more →4 March 2026
Syntropic Medical completes Phase IIa LUX study of HAVEN™, an investigational, non-invasive light-based approach for depression
Syntropic Medical completes Phase IIa LUX study of HAVEN™, an investigational, non-invasive light-based approach for depression Early clinical evaluation in Brazil supports safety and tolerability…
Read more →21 October 2025
Syntropic: Klosterneuburger MedTech startet Kooperationen in Brasilien und New York
By Momcilo Nikolic 20.10.2025 Syntropic: Klosterneuburger MedTech startet Kooperationen in Brasilien und New York Das NÖ-MedTech-Startup Syntropic hat abseits medialer Aufmerksamkeit erste klinische Erfolge gefeiert…
Read more →17 October 2025
Syntropic Medical publishes first-in-human study on novel light therapy technology in PLOS One
Syntropic Medical publishes first–in–human study on novel light therapy technology in PLOS One Vienna, 7. October 2025 On October 7, 2025, Syntropic Medical has announced…
Read more →16 October 2025
Best of Biotech 2025 Winner
Best of Biotech 2025 Winner Credit: © Vogus / Wolfgang Voglhuber Syntropic Medical has been awarded Best of Biotech 2025 in the Medtech Start-up category….
Read more →9 September 2025
Syntropic initiates first patient stimulation in home-based depression clinical trial
Vienna, Austria, September 5, 2025 Syntropic initiates first patient stimulation in home-based depression clinical trial On September 5, 2025, the company reached a key clinical…
Read more →6 August 2025
Syntropic Medical receives IRB approval for new home-based light therapy clinical trial
Vienna, Austria, August 4, 2025 Syntropic Medical receives IRB approval for new home-based light therapy clinical trial On July 15, 2025, Syntropic Medical reached a…
Read more →25 July 2025
Syntropic Medical completes first patient stimulation in depression clinical trial
Vienna, Austria, July 23, 2025 Syntropic Medical completes first patient stimulation in depression clinical trial On May 5, 2025, Syntropic Medical completed the first full…
Read more →27 March 2025
Meet Troy Dale, Strategic Advisor and Investor
Troy Dale Strategic Advisor and Investor Troy Dale, who originally trained as a Pharmacologist has over 30 years of experience in the pharmaceutical industry, spanning…
Read more →Get Involved
Rapid Neuroplasticity therapy for depression.
Join the clinical program. Partner with us.
Invest in the future of depression treatment.